Tyche Wealth Partners LLC acquired a new position in CVS Health Co. (NYSE:CVS – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,552 shares of the pharmacy operator’s stock, valued at approximately $202,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Bryn Mawr Capital Management LLC increased its stake in shares of CVS Health by 74.0% in the third quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock worth $3,017,000 after purchasing an additional 18,385 shares in the last quarter. Value Partners Investments Inc. grew its stake in CVS Health by 26.5% during the third quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock valued at $69,261,000 after acquiring an additional 207,702 shares in the last quarter. Sonora Investment Management Group LLC grew its stake in CVS Health by 1.6% during the third quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after acquiring an additional 774 shares in the last quarter. Checchi Capital Advisers LLC grew its stake in CVS Health by 2.3% during the third quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock valued at $726,000 after acquiring an additional 233 shares in the last quarter. Finally, Personal CFO Solutions LLC grew its stake in CVS Health by 2.6% during the third quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock valued at $1,351,000 after acquiring an additional 491 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at CVS Health
In related news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is currently owned by company insiders.
Analyst Ratings Changes
View Our Latest Stock Report on CVS
CVS Health Price Performance
CVS Health stock opened at $69.39 on Friday. The firm has a 50-day moving average price of $75.42 and a 200-day moving average price of $73.70. The firm has a market capitalization of $87.46 billion, a PE ratio of 10.74, a price-to-earnings-growth ratio of 0.91 and a beta of 0.52. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Co. has a 12-month low of $64.41 and a 12-month high of $83.25.
CVS Health (NYSE:CVS – Get Free Report) last released its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.11. The firm had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business’s revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the business earned $1.99 EPS. As a group, equities research analysts forecast that CVS Health Co. will post 8.32 EPS for the current year.
CVS Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.83%. CVS Health’s payout ratio is 41.18%.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- Using the MarketBeat Stock Split Calculator
- Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
- Industrial Products Stocks Investing
- Comprehensive PepsiCo Stock Analysis
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.